Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Scarborough, Maine
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Conditions: Sarcoma
Location: Scarborough, Maine
- Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastom
Conditions: Brain and Central Nervous System Tumors
Location: Scarborough, Maine
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Conditions: Sarcoma
Location: Scarborough, Maine
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Portland, Maine
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: York, Maine
- Randomized On-X Anticoagulation Trial
Conditions: Heart Valve Disease
Location: Portland, Maine
- Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Su
Conditions: Esophageal Cancer
Location: Scarborough, Maine
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Conditions: Kidney Cancer
Location: Scarborough, Maine
- Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
Conditions: Hodgkin's Lymphoma
Location: Portland, Maine
- Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surge
Conditions: Kidney Cancer
Location: Scarborough, Maine
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Conditions: Sarcoma
Location: Scarborough, Maine
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Scarborough, Maine
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Portland, Maine
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: York, Maine
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Scarborough, Maine
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Scarborough, Maine
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Conditions: Brain and Central Nervous System Tumors
Location: Scarborough, Maine
- Implementation of Practice Standards for ECG Monitoring
Conditions: Cardiovascular Disease
Location: Portland, Maine
- Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Scarborough, Maine
- Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neurob
Conditions: Neuroblastoma
Location: Scarborough, Maine
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Gloucester, Massachusetts
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Scarborough, Maine
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: York, Maine
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Methuen, Massachusetts
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Gloucester, Massachusetts
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Methuen, Massachusetts
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Portland, Maine
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: York, Maine
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Portland, Maine
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Scarborough, Maine
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Biddeford, Maine
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: South Portland, Maine
- Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergo
Conditions: Breast Cancer - Lymphedema - Perioperative/Postoperative Complications
Location: York, Maine
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Scarborough, Maine
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Scarborough, Maine
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Portland, Maine
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Scarborough, Maine
- Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Gloucester, Massachusetts
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Beverly, Massachusetts
- Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus
Conditions: Kidney Transplant - Kidney Transplantation - Renal Transplant
Location: Portland, Maine
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
Conditions: Parkinson's Disease Psychosis
Location: Scarborough, Maine
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Gloucester, Massachusetts
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Methuen, Massachusetts
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Gloucester, Massachusetts
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Gloucester, Massachusetts
- Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra
Conditions: Aortic Valve Insufficiency - Aortic Valve Regurgitation - Aortic Valve Stenosis - Aortic Valve Incompetence - Mitral Valve Insufficiency - Mitral Valve Regurgitation - Mitral Valve Stenosis - Mitral Valve Incompetence
Location: Portland, Maine
- Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Conditions: Alzheimer Disease
Location: Haverhill, Massachusetts
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Gloucester, Massachusetts
- Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Scarborough, Maine
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: York, Maine
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Gloucester, Massachusetts
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Gloucester, Massachusetts
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis - Venous Thrombosis - Postphlebitic Syndrome - Venous Thromboembolism - Post Thrombotic Syndrome
Location: Portland, Maine
- OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Conditions: Heart Failure
Location: Newburyport, Massachusetts
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Portland, Maine
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Portland, Maine
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Gloucester, Massachusetts
- Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Portland, Maine
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: Kittery, Maine
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: Wells, Maine
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: York, Maine
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: York, Maine
- Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma
Location: Scarborough, Maine
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Ca
Conditions: Breast Cancer
Location: Scarborough, Maine
- Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Conditions: Cervical Cancer - Precancerous Condition
Location: Portland, Maine
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Portland, Maine
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: York, Maine
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Scarborough, Maine
- Study of Kidney Tumors in Young Patients
Conditions: Kidney Cancer - Nonneoplastic Condition
Location: Scarborough, Maine
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Portland, Maine
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Conditions: Neuroblastoma
Location: Scarborough, Maine
- Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Portland, Maine
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Conditions: Glioblastoma Multiforme
Location: Scarborough, Maine
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Conditions: Chordoma - Desmoid Tumor - Sarcoma
Location: Scarborough, Maine
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Scarborough, Maine
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Methuen, Massachusetts
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Scarborough, Maine
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Portland, Maine
- Study of Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Advanced Non-Small Cell Lung Cancer
Location: Portland, Maine
- Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patient
Conditions: Endometrial Cancer
Location: Portland, Maine
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
Conditions: Liver Cancer
Location: Scarborough, Maine
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
Location: Scarborough, Maine
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Portland, Maine
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Portland, Maine
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: York, Maine
- A Study for Patients With Small-Cell Lung Cancer
Conditions: Small Cell Lung Cancer
Location: Scarborough, Maine
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Gloucester, Massachusetts
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Haverhill, Massachusetts
- Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Conditions: Prostate Cancer
Location: Scarborough, Maine
- A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Ind
Conditions: Non-Hodgkin's Lymphoma
Location: Scarborough, Maine
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Portland, Maine
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-
Conditions: Squamous Cell Lung Cancer
Location: Scarborough, Maine
- A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Conditions: Head and Neck Neoplasms
Location: Scarborough, Maine
- Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combina
Conditions: Chemotherapeutic Agent Toxicity - Colorectal Cancer - Neuropathy - Neurotoxicity
Location: York, Maine
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Conditions: Breast Cancer
Location: York, Maine
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Gloucester, Massachusetts
- A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic B
Conditions: Breast Cancer
Location: Scarborough, Maine
- A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic B
Conditions: Breast Cancer
Location: York, Maine
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: York, Maine
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Gloucester, Massachusetts
- Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
Conditions: Endometrial Cancer
Location: Portland, Maine
- Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
Conditions: Breast Cancer - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Portland, Maine
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Scarborough, Maine
- Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
Conditions: Brain Injuries
Location: Portland, Maine
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Gloucester, Massachusetts
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Methuen, Massachusetts
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: York, Maine
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Biddeford, Maine
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Sanford, Maine
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Scarborough, Maine
- A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
Conditions: Parkinson's Disease Psychosis
Location: Scarborough, Maine
- A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
Conditions: Hypertension, Pulmonary
Location: Portland, Maine
- A Study in Second Line Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Scarborough, Maine
- A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To S
Conditions: Psoriasis
Location: Beverly, Massachusetts
- A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To S
Conditions: Psoriasis
Location: Haverhill, Massachusetts
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Scarborough, Maine
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Portland, Maine
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
Location: Scarborough, Maine
- The Vitality, Independence, and Vigor in Elders Study I Clinical Trial
Conditions: Functional Mobility, Vitamin D Status, Bio-markers of Muscle Health, and Psychosocial Factors Such as Well-being.
Location: Methuen, Massachusetts
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Portland, Maine
- AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer
Conditions: Endometrial Cancer
Location: Portland, Maine
- I Change Adherence & Raise Expectations
Conditions: Cystic Fibrosis
Location: Portland, Maine
- Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma
Conditions: Lymphoma, Follicular
Location: Scarborough, Maine
- Bone Marrow Aspirate Concentrate (BMAC) for Treatment of Critical Limb Ischemia (CLI)
Conditions: Critical Limb Ischemia Due to Peripheral Arterial Occlusive Disease
Location: Portland, Maine
- A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-Remitting
Location: Scarbrough, Maine
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Gloucester, Massachusetts
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Methuen, Massachusetts
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Melanoma (Skin)
Location: Scarborough, Maine
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Melanoma (Skin)
Location: York, Maine
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Breast Cancer
Location: Gloucester, Massachusetts
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Breast Cancer
Location: Methuen, Massachusetts
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Breast Cancer
Location: Scarborough, Maine
- Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders
Location: York, Maine
- A Study of Obinutuzumab (RO5072759) in Combination With CHOP Chemotherapy Versus MabThera/Rituxan (Rituximab) With CHOP in Patients With CD20-Positive
Conditions: Lymphoma, B-Cell
Location: Portland, Maine
- Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Scarborough, Maine
- Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavi
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Portland, Maine
- Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
Conditions: Type I Diabetes
Location: Haverhill, Massachusetts
- Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain
Conditions: Pegfilgrastim-induced Back and Leg Pain
Location: Scarborough, Maine
- Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain
Conditions: Pegfilgrastim-induced Back and Leg Pain
Location: York, Maine
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Portland, Maine
- A Study of Avastin (Bevacizumab) in Combination With Standard of Care Treatment in Patients With Lung Cancer
Conditions: Non-Small Cell Lung Cancer
Location: York, Maine
- Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Conditions: Renal Insufficiency, Chronic - Diabetes Mellitus, Type 2
Location: Biddeford, Maine
- Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe
Conditions: Low Back Pain
Location: Haverhill, Massachusetts
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Scarborough, Maine
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Portland, Maine
- Study of Bevacizumab/mFOLFOX6 Versus Bevacizumab/Folfiri With Biomarker Stratification in Patients With Previously Untreated Metastatic Colorectal Can
Conditions: Colorectal Cancer
Location: Biddeford, Maine
- Study of Bevacizumab/mFOLFOX6 Versus Bevacizumab/Folfiri With Biomarker Stratification in Patients With Previously Untreated Metastatic Colorectal Can
Conditions: Colorectal Cancer
Location: Sanford, Maine
- Study of Bevacizumab/mFOLFOX6 Versus Bevacizumab/Folfiri With Biomarker Stratification in Patients With Previously Untreated Metastatic Colorectal Can
Conditions: Colorectal Cancer
Location: Scarborough, Maine
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Conditions: Pulmonary Arterial Hypertension
Location: Portland, Maine
- X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey
Conditions: Hypohidrotic Ectodermal Dysplasia - X-Linked Hypohidrotic Ectodermal Dysplasia
Location: Portland, Maine
- Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Conditions: Metastatic Breast Cancer
Location: Portland, Maine
- The OMEGA Clinical Trial
Conditions: Atherosclerosis - Coronary Artery Disease
Location: Portland, Maine
- A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Patients With HER2-Positive Breast Cancer Who Have Received at
Conditions: Breast Cancer
Location: Scarborough, Maine
- The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass
Conditions: Blood Coagulation Disorders
Location: Portland, Maine
- A Study in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Haverhill, Massachusetts
- Open Label Study of Long Term Evaluation Against LDL-C Trial (OSLER)
Conditions: Hypercholesterolemia
Location: Portland, Maine
- A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
Conditions: Endometrial Carcinoma
Location: Scarborough, Maine
- Phase 3 Papulopustular Rosacea Study
Conditions: Papulopustular Rosacea
Location: Beverly, Massachusetts
- A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Conditions: Major Depressive Disorder
Location: Haverhill, Massachusetts
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Haverhill, Massachusetts
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Concord, New Hampshire
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Exeter, New Hampshire
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Hooksett, New Hampshire
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Londonderry, New Hampshire
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Manchester, New Hampshire
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Concord, New Hampshire
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Exeter, New Hampshire
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Manchester, New Hampshire
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Manchester, New Hampshire
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Conditions: Lymphoma
Location: Concord, New Hampshire
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Conditions: Lymphoma
Location: Hooksett, New Hampshire
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Conditions: Lymphoma
Location: Laconia, New Hampshire
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Concord, New Hampshire
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Exeter, New Hampshire
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Hooksett, New Hampshire
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Laconia, New Hampshire
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Manchester, New Hampshire
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Manchester, New Hampshire
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Exeter, New Hampshire
- Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Su
Conditions: Esophageal Cancer
Location: Concord, New Hampshire
- Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Su
Conditions: Esophageal Cancer
Location: Hooksett, New Hampshire
- Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Su
Conditions: Esophageal Cancer
Location: Laconia, New Hampshire
- Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Su
Conditions: Esophageal Cancer
Location: Manchester, New Hampshire
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Dover, New Hampshire
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Exeter, New Hampshire
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Exeter, New Hampshire
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Haverhill, Massachusetts
- Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Fatigue - Metastatic Cancer - Psychosocial Effects of Cancer and Its Treatment - Radiation Toxicity
Location: Hooksett, New Hampshire
- Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Fatigue - Metastatic Cancer - Psychosocial Effects of Cancer and Its Treatment - Radiation Toxicity
Location: Laconia, New Hampshire
- Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Breast Cancer - Cognitive/Functional Effects - Lung Cancer - Metastatic Cancer - Prostate Cancer
Location: Dover, New Hampshire
- Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Breast Cancer - Cognitive/Functional Effects - Lung Cancer - Metastatic Cancer - Prostate Cancer
Location: Manchester, New Hampshire
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Concord, New Hampshire
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Exeter, New Hampshire
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Hooksett, New Hampshire
- Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Concord, New Hampshire
- Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Hooksett, New Hampshire
- Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Laconia, New Hampshire
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Conditions: Endometrial Cancer
Location: Manchester, New Hampshire
- Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer
Conditions: Breast Cancer
Location: Hooksett, New Hampshire
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III
Conditions: Lung Cancer
Location: Concord, New Hampshire
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III
Conditions: Lung Cancer
Location: Hooksett, New Hampshire
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III
Conditions: Lung Cancer
Location: Laconia, New Hampshire
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III
Conditions: Lung Cancer
Location: Manchester, New Hampshire
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Exeter, New Hampshire
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Concord, New Hampshire
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Hooksett, New Hampshire
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Laconia, New Hampshire
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Concord, New Hampshire
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Hooksett, New Hampshire
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Laconia, New Hampshire
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Manchester, New Hampshire
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Exeter, New Hampshire
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Manchester, New Hampshire
- Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra
Conditions: Aortic Valve Insufficiency - Aortic Valve Regurgitation - Aortic Valve Stenosis - Aortic Valve Incompetence - Mitral Valve Insufficiency - Mitral Valve Regurgitation - Mitral Valve Stenosis - Mitral Valve Incompetence
Location: Manchester, New Hampshire
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Concord, New Hampshire
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Dover, New Hampshire
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Exeter, New Hampshire
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Manchester, New Hampshire
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Concord, New Hampshire
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Exeter, New Hampshire
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Hooksett, New Hampshire
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Laconia, New Hampshire
- Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Exeter, New Hampshire
- Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Laconia, New Hampshire
- A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol
Conditions: Post-Traumatic Stress Disorder
Location: Manchester, New Hampshire
- A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
Conditions: Optic Neuropathy, Ischemic
Location: Manchester, New Hampshire
- A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
Conditions: Optic Neuropathy, Ischemic
Location: Beverly, Massachusetts
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Concord, New Hampshire
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Dover, New Hampshire
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Exeter, New Hampshire
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Hooksett, New Hampshire
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Laconia, New Hampshire
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Manchester, New Hampshire
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Concord, New Hampshire
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Hooksett, New Hampshire
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Laconia, New Hampshire
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Manchester, New Hampshire
- Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
Conditions: Type 2 Diabetes Mellitus
Location: Rochester, New Hampshire
- Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
Conditions: Type 2 Diabetes Mellitus
Location: Haverhill, Massachusetts
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Manchester, New Hampshire
- Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Portsmouth, New Hampshire
- Atorvastatin Three Year Pediatric Study
Conditions: Familial Hypercholesterolemia
Location: Concord, New Hampshire
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Manchester, New Hampshire
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Ca
Conditions: Breast Cancer
Location: Concord, New Hampshire
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Ca
Conditions: Breast Cancer
Location: Exeter, New Hampshire
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Ca
Conditions: Breast Cancer
Location: Hooksett, New Hampshire
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Ca
Conditions: Breast Cancer
Location: Laconia, New Hampshire
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Ca
Conditions: Breast Cancer
Location: Manchester, New Hampshire
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Methuen, Massachusetts
|